| Primary |
| Unevaluable Event |
34.8% |
| Diabetes Mellitus |
26.3% |
| Type 2 Diabetes Mellitus |
11.0% |
| Drug Use For Unknown Indication |
7.8% |
| Hypertension |
6.3% |
| Myelodysplastic Syndrome |
2.3% |
| Atrial Fibrillation |
1.3% |
| Headache |
1.3% |
| Back Pain |
1.0% |
| Blood Pressure |
1.0% |
| Duodenitis |
1.0% |
| Essential Hypertension |
1.0% |
| Hypoglycaemia |
1.0% |
| Product Used For Unknown Indication |
1.0% |
| Hyperuricaemia |
0.8% |
| Arrhythmia |
0.5% |
| Asthenia |
0.5% |
| Deep Vein Thrombosis |
0.5% |
| Diabetes Mellitus Management |
0.5% |
| Diabetes Mellitus Non-insulin-dependent |
0.5% |
|
| Renal Failure Acute |
15.0% |
| Vomiting |
12.5% |
| Pancreatitis Acute |
8.8% |
| Pneumatosis Intestinalis |
8.8% |
| Weight Decreased |
6.3% |
| Abdominal Distension |
5.0% |
| Hypoglycaemia |
5.0% |
| Dizziness |
3.8% |
| Glaucoma |
3.8% |
| Pruritus |
3.8% |
| Pyrexia |
3.8% |
| Tongue Oedema |
3.8% |
| Alopecia |
2.5% |
| Angioedema |
2.5% |
| Cardiac Failure Congestive |
2.5% |
| Flatulence |
2.5% |
| Intestinal Obstruction |
2.5% |
| Oesophageal Carcinoma |
2.5% |
| Periorbital Oedema |
2.5% |
| Petechiae |
2.5% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
29.9% |
| Diabetes Mellitus |
20.4% |
| Product Used For Unknown Indication |
12.5% |
| Drug Use For Unknown Indication |
12.1% |
| Hypertension |
8.5% |
| Hypercholesterolaemia |
2.8% |
| Diabetes Mellitus Non-insulin-dependent |
2.5% |
| Depression |
1.9% |
| Atrial Fibrillation |
1.5% |
| Rheumatoid Arthritis |
1.3% |
| Angina Pectoris |
0.8% |
| Dyslipidaemia |
0.8% |
| Prophylaxis |
0.8% |
| Anxiety |
0.6% |
| Diabetic Dyslipidaemia |
0.6% |
| Fungal Infection |
0.6% |
| Hyperlipidaemia |
0.6% |
| Prostate Cancer |
0.6% |
| Asthenia |
0.4% |
| Bladder Cancer |
0.4% |
|
| Hypoglycaemia |
13.4% |
| Renal Failure |
10.4% |
| Renal Failure Acute |
10.4% |
| Pleural Mesothelioma |
9.0% |
| Diarrhoea |
4.5% |
| Drug Interaction |
4.5% |
| Infarction |
4.5% |
| Pancreatitis |
4.5% |
| Pyrexia |
4.5% |
| Vomiting |
4.5% |
| Blood Creatinine Increased |
3.0% |
| Cardiac Failure |
3.0% |
| Diabetes Mellitus Inadequate Control |
3.0% |
| Fall |
3.0% |
| Gastric Ulcer Haemorrhage |
3.0% |
| Hepatitis Cholestatic |
3.0% |
| Hepatitis E |
3.0% |
| Hospitalisation |
3.0% |
| Hypersensitivity |
3.0% |
| Hyponatraemia |
3.0% |
|
| Concomitant |
| Diabetes Mellitus |
19.0% |
| Drug Use For Unknown Indication |
18.7% |
| Product Used For Unknown Indication |
18.3% |
| Type 2 Diabetes Mellitus |
11.1% |
| Hypertension |
10.5% |
| Prophylaxis |
2.8% |
| Pain |
2.0% |
| Rheumatoid Arthritis |
1.8% |
| Hepatitis C |
1.8% |
| Hypercholesterolaemia |
1.6% |
| Hyperlipidaemia |
1.5% |
| Benign Prostatic Hyperplasia |
1.4% |
| Angina Pectoris |
1.4% |
| Diabetes Mellitus Non-insulin-dependent |
1.3% |
| Dyslipidaemia |
1.3% |
| Diffuse Large B-cell Lymphoma |
1.1% |
| Hypothyroidism |
1.1% |
| Insomnia |
1.1% |
| Atrial Fibrillation |
1.1% |
| Coronary Artery Disease |
1.1% |
|
| Renal Failure Acute |
10.9% |
| Hypoglycaemia |
10.4% |
| Vomiting |
8.5% |
| Renal Failure |
6.6% |
| Weight Increased |
6.2% |
| Weight Decreased |
5.7% |
| Cardiac Arrest |
5.2% |
| Myocardial Infarction |
4.7% |
| Pneumonia |
4.3% |
| Pyrexia |
4.3% |
| Urinary Retention |
4.3% |
| Urinary Tract Infection |
4.3% |
| Malaise |
3.3% |
| Myalgia |
3.3% |
| Nausea |
3.3% |
| Tremor |
3.3% |
| Death |
2.8% |
| Hyperkalaemia |
2.8% |
| Oedema Peripheral |
2.8% |
| Pain |
2.8% |
|
| Interacting |
| Diabetes Mellitus |
50.0% |
| Coronary Artery Disease |
25.0% |
| Headache |
25.0% |
|
| Drug Interaction |
33.3% |
| Hypoglycaemia |
33.3% |
| Potentiating Drug Interaction |
33.3% |
|
